Darwin Wealth Management’s West Pharmaceutical WST Stock Holding History

Darwin Wealth Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69K	Hold	10	–	–	﹤0.01%	470
2026 Q1	$2.6K	Sell	10 -400	-98%	-$99.5K	﹤0.01%	470
2025 Q4	$113K	Buy	410 +40	+11%	+$10.9K	0.04%	166
2025 Q3	$97.1K	Buy	370 +26	+8%	+$6.32K	0.03%	178
2025 Q2	$75.3K	Buy	344 +3	+0.9%	+$641	0.03%	181
2025 Q1	$112K	Hold	341	–	–	0.04%	169
2024 Q4	$112K	Sell	341 -7	-2%	-$2.2K	0.04%	169
2024 Q3	$104K	Buy	+348	New	+$107K	0.03%	181
2020 Q4	–	Sell	-10,830	Closed	-$2.98M	–	180
2020 Q3	$2.98M	Buy	+10,830	New	+$2.87M	0.64%	46

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Darwin Wealth Management's WST Position: Q2 2026 in Review

Darwin Wealth Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 10 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Darwin Wealth Management first reported a position in WST in Q3 2020 and has held it in 9 quarters since. The position peaked at $2.98M in Q3 2020. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Darwin Wealth Management held 10 shares of West Pharmaceutical worth $3.69K as of Q2 2026.
Darwin Wealth Management left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #470 holding.
Darwin Wealth Management first reported a position in West Pharmaceutical in Q3 2020 and has held it in 9 quarters since.
Darwin Wealth Management's West Pharmaceutical position peaked at $2.98M in Q3 2020.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.